Home/Filings/4/0001104659-16-159835
4//SEC Filing

Aralez Pharmaceuticals Inc. 4

Accession 0001104659-16-159835

CIK 0001660719operating

Filed

Nov 29, 7:00 PM ET

Accepted

Nov 30, 7:56 PM ET

Size

15.9 KB

Accession

0001104659-16-159835

Insider Transaction Report

Form 4
Period: 2016-11-28
Transactions
  • Sale

    Common Shares, without par value

    2016-11-28$4.65/sh20,000$93,000594,094 total
  • Exercise/Conversion

    Common Shares, without par value

    2016-11-29$3.92/sh+104,778$410,730698,872 total
  • Sale

    Common Shares, without par value

    2016-11-29$4.99/sh104,778$523,146594,094 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2016-11-2820,000104,778 total
    Exercise: $3.92Exp: 2016-12-01Common Shares, without par value (20,000 underlying)
  • Exercise/Conversion

    Common Shares, without par value

    2016-11-28$3.92/sh+20,000$78,400614,094 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2016-11-29104,7780 total
    Exercise: $3.92Exp: 2016-12-01Common Shares, without par value (104,778 underlying)
Holdings
  • Common Shares, without par value

    (indirect: By Spouse)
    600,188
Footnotes (6)
  • [F1]Price is presented in Canadian dollars.
  • [F2]The exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2016, as amended.
  • [F3]Price is presented in United States dollars.
  • [F4]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2016, as amended.
  • [F5]This transaction was executed in multiple trades at prices ranging from $4.76 to $5.10. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F6]The option was exercisable as of the Reporting Person's previous filing on Form 3, dated as of February 8, 2016.

Documents

1 file

Issuer

Aralez Pharmaceuticals Inc.

CIK 0001660719

Entity typeoperating
IncorporatedBritish Columbia, Canada

Related Parties

1
  • filerCIK 0001660719

Filing Metadata

Form type
4
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 7:56 PM ET
Size
15.9 KB